Copyright
©The Author(s) 2025.
World J Hepatol. Feb 27, 2025; 17(2): 99292
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.99292
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.99292
Figure 1 CGAS protein expression in presence of hepatitis B virus.
A: CGAS protein expression in HepG2.2.15 cells vs HepG2 cells; B: CGAS mRNA levels in HepG2.2.15 cells vs HepG2 cells; C: CGAS protein expression in HepG2-NTCP cells treated with hepatitis B virus (HBV) from HepG2.2.15 cells supernatant after 72 hours; D: CGAS mRNA levels in HepG2-NTCP cells treated with HBV from HepG2.2.15 cells supernatant after 72 hours; E: CGAS protein expression in HepG2 cells transfected with different doses of pHBV1.3; F: CGAS mRNA levels in HepG2 cells transfected with different doses of pHBV1.3. Each experiment was repeated three times. Data are presented as mean ± SD.
- Citation: Xu ZY, Gao JS, He Y, Xiao XQ, Gong GZ, Zhang M. Hepatitis B virus confers innate immunity evasion through hepatitis B virus-miR-3 down-regulation of cGAS-Sting-IFN signaling. World J Hepatol 2025; 17(2): 99292
- URL: https://www.wjgnet.com/1948-5182/full/v17/i2/99292.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i2.99292